Methyltransferase Like 2B (METTL2B) Peptide
METTL2B
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all METTL2B products
- METTL2B (Methyltransferase Like 2B (METTL2B))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-METTL2B antibody (Catalog #: ARP48837_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- METTL2B (Methyltransferase Like 2B (METTL2B))
- Synonyms
- METL Peptide, METTL2 Peptide, METTL2A Peptide, PSENIP1 Peptide, Mettl2 Peptide, methyltransferase like 2B Peptide, METTL2B Peptide, Mettl2b Peptide
- Background
-
METTL2B is a member of a family of methyltransferases that share homology with, but are distinct from, the UbiE family of methyltransferases.This gene is a member of a family of methyltransferases that share homology with, but are distinct from, the UbiE family of methyltransferases. Alternatively spliced variants which encode different protein isoforms have been described, however, not all variants have been fully characterized.
Alias Symbols: FLJ11350, FLJ12760, METL, METTL2, METTL2A, PSENIP1
Protein Size: 378 - Molecular Weight
- 43 kDa
- Gene ID
- 55798
- NCBI Accession
- NM_018396, NP_060866
- UniProt
- Q6P1Q9
-
You are here:
